1. Home
  2. VERA vs UE Comparison

VERA vs UE Comparison

Compare VERA & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • UE
  • Stock Information
  • Founded
  • VERA 2016
  • UE 2014
  • Country
  • VERA United States
  • UE United States
  • Employees
  • VERA N/A
  • UE N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • VERA Health Care
  • UE Finance
  • Exchange
  • VERA Nasdaq
  • UE Nasdaq
  • Market Cap
  • VERA 2.5B
  • UE 2.4B
  • IPO Year
  • VERA 2021
  • UE N/A
  • Fundamental
  • Price
  • VERA $46.26
  • UE $22.95
  • Analyst Decision
  • VERA Strong Buy
  • UE Hold
  • Analyst Count
  • VERA 9
  • UE 2
  • Target Price
  • VERA $54.33
  • UE $20.00
  • AVG Volume (30 Days)
  • VERA 1.1M
  • UE 816.2K
  • Earning Date
  • VERA 11-07-2024
  • UE 10-30-2024
  • Dividend Yield
  • VERA N/A
  • UE 2.96%
  • EPS Growth
  • VERA N/A
  • UE 533.18
  • EPS
  • VERA N/A
  • UE 2.20
  • Revenue
  • VERA N/A
  • UE $435,181,000.00
  • Revenue This Year
  • VERA N/A
  • UE N/A
  • Revenue Next Year
  • VERA N/A
  • UE $3.72
  • P/E Ratio
  • VERA N/A
  • UE $10.41
  • Revenue Growth
  • VERA N/A
  • UE 8.27
  • 52 Week Low
  • VERA $12.28
  • UE $15.81
  • 52 Week High
  • VERA $51.61
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • VERA 54.02
  • UE 59.23
  • Support Level
  • VERA $47.16
  • UE $22.85
  • Resistance Level
  • VERA $51.61
  • UE $23.85
  • Average True Range (ATR)
  • VERA 2.99
  • UE 0.55
  • MACD
  • VERA 0.21
  • UE 0.00
  • Stochastic Oscillator
  • VERA 52.82
  • UE 53.71

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: